进展性缺血性卒中的药物治疗进展研究  

Advances in Drug Treatment of Progressive Ischemic Stroke

作　　者：王秀丽 阮明军 WANG Xiuli;RUAN Mingjun(Department of Encephalopathy,Jining Hospital,Xiyuan Hospital,Jining 272000,Shandong,China)

机构地区：[1]西苑医院济宁医院脑病科,山东济宁272000

出　　处：《系统医学》2025年第6期192-194,共3页Systems Medicine

摘　　要：进展性缺血性卒中作为临床常见的脑血管疾病,相较于稳定型卒中,其治疗难度大大增加。药物治疗为临床常见治疗方式,但由于进展性缺血性卒中有着极高的致残率和致死率,药物的选择关系到患者病情的控制程度以及预后,因此,必须慎之又慎。鉴于此,文章结合相关资料,从该病的基础定义出发,研究其病因机制,并对其治疗方式进行分析,最终结合其他学者的相关研究作此综述,以期能为相关人员提供参考。As a common clinical cerebrovascular disease,progressive ischemic stroke is more difficult to treat than stable stroke.Drug therapy is a common clinical treatment,but because of the high disability rate and mortality rate of progressive ischemic stroke,the choice of drugs is related to the control degree and prognosis of the patient's condi-tion.Therefore,it must be cautious.In view of this,this article combines relevant data,starting from the basic defini-tion of the disease,studies its etiology and mechanism,and analyzes its treatment methods.Finally,it combines the relevant research of other scholars to make this review,in order to provide reference for relevant personnel.

关 键 词：进展性缺血性卒中 药物治疗 抗凝治疗 中药治疗 

分 类 号：R4[医药卫生—临床医学]